Author

Sabina Valova

Princess Máxima Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Assay:imaging· 1 Approach:microscopy & imaging analysis· 1

Frequent Co-Authors

Eleonora J. Looze· 2 shared Jan J. MolenaariD· 2 shared Marlinde C. SchoonbeekiD· 2 shared Marlinde L. van den BoogaardiD· 2 shared Sander R. van HooffiD· 2 shared Selma Eising· 2 shared Alexandra Saint‐CharlesiD· 1 shared Angelika EggertiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Eleonora J. Looze

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A microscopy-based readout to assess tumour-specific viability in neuroblastoma co-cultures and short-term cultured patient samples

Marlinde C. Schoonbeek, Sabina Valova, Sarah E. M. Swaak, Eleonora J. Looze, Merle M.J. Watzeels, Luca M. van den Brink, Mario Barrera Román, Jeroen F. van Velzen, Eoghan O’Duibhir, Karin P.S. Langenberg, Judith Wienke, Sander R. van Hooff, Marlinde L. van den Boogaard, Selma Eising, Jan J. Molenaar

This paper introduces a microscopy-based method to measure tumour-specific viability in neuroblastoma co-cultures and patient samples, enabling more accurate drug response assessment.

bioRxiv · Jun 25, 2026 · PreprintCancer Biology

Sensitivity profiling reveals consistent drug responses across preclinical neuroblastoma models

Marlinde C. Schoonbeek, Marloes van Luik, Heike Peterziel, Dennis Gürgen, Vicky Amo-Addae, Lindy Vernooij, Eleonora J. Looze, Sabina Valova, Sina Kreth, Jan Köster, Angelika Eggert, Julia B. Schüler, Aniello Federico, Apurva Gopisetty, Benjamin Schwalm, , Sander R. van Hooff

This study compares ex vivo short-term, organoid, and PDX drug screening methods in neuroblastoma, finding ex vivo screens are faster and more consistent with in vivo results.

bioRxiv · Feb 25, 2026 · PreprintCell Biology